Last reviewed · How we verify

Antidepressants

Fundació Sant Joan de Déu · FDA-approved active Small molecule

Antidepressants is a Small molecule drug developed by Fundació Sant Joan de Déu. It is currently FDA-approved. Also known as: Fluoxetine, Pharmacotherapy, Control, Antidepressant medication.

At a glance

Generic nameAntidepressants
Also known asFluoxetine, Pharmacotherapy, Control, Antidepressant medication
SponsorFundació Sant Joan de Déu
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Antidepressants

What is Antidepressants?

Antidepressants is a Small molecule drug developed by Fundació Sant Joan de Déu.

Who makes Antidepressants?

Antidepressants is developed and marketed by Fundació Sant Joan de Déu (see full Fundació Sant Joan de Déu pipeline at /company/fundaci-sant-joan-de-d-u).

Is Antidepressants also known as anything else?

Antidepressants is also known as Fluoxetine, Pharmacotherapy, Control, Antidepressant medication.

What development phase is Antidepressants in?

Antidepressants is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing